Upper gastrointestinal endoscopy is the key examination for screening for precancerous and cancerous lesions of the esophagus and stomach. This study aims to describe the quality of the visualization of the esophageal and gastric mucosa, the safety of use of two fasting procedures before gastroscopy and the feeling of patients. The population evaluated here concerns cirrhotic patients, at high risk of developing a precancerous lesion of the upper gastrointestinal tract. The investigator carries out a prospective, monocentric (Besançon CHRU), interventional and randomized study according to two fasting procedures before gastroscopy: 6 hours (F6 group) versus 2 hours (F2 group) for clear fluids. The primary endpoint was to describe and compare the quality of visualization of the esophageal and gastric mucosa, graded from A (good quality) to C (poor quality) according to a score. developed by Elvas et al. (Endoscopy 2017).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
70
fasting before gastrointestinal endoscopy
Centre Hospitalier Universitaire
Besançon, France
Score for quality of visualization of the esophageal and gastric mucosa
The score is graded from A (good quality) to C (poor quality) according to a score developed by Elvas et al. (Endoscopy 2017).
Time frame: During endoscopy
Questionnaire concerning security
Questionnaire filled by the investigator concerning the side effectets observed or not observed
Time frame: During endoscopy
Questionnaire concerning patient confort during fasting
Snsations felt or not felt by the patients
Time frame: The day of the endoscopy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.